Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is sponsoring university research on light waves reacting in characteristic patterns for de… https://t.co/RG11kdD0as
    about 18 hours ago
  • New post on Science and Enterprise: Univ Lab, Company Developing Phone-Based Virus Sensor https://t.co/Yqq5wZPmqF #Science #Business
    about 18 hours ago
  • A blood test designed for low-resource field settings is shown to quickly detect and distinguish between different… https://t.co/7RCwijmW7N
    about 1 day ago
  • New post on Science and Enterprise: Quick Crispr-Based Test Detects Malaria in Blood https://t.co/LuZnLHRUYW #Science #Business
    about 1 day ago
  • Researchers in the U.K. created a bandage with enhanced human skeletal stem cells that in lab mice repairs simulate… https://t.co/1tD7FxaoRo
    about 2 days ago

Please share Science & Enterprise

Bristol-Myers Squibb, Biotech Partner on Alzheimer’s Test

Brain scan (National Institute of Mental Health)

(National Institute of Mental Health)

Opko Health Inc., a biotechnology company in Miami, Florida, said today it has a collaboration agreement with the drug manufacturer Bristol-Myers Squibb Company for Opko’s diagnostic test technology. Opko’s blood tests are being developed from its technology that identifies biomarkers for a range of diseases including neurodegenerative disorders.

Part of the project calls for Opko and Bristol-Myers Squibb to investigate the potential for Opko’s technology to diagnose Alzheimer’s disease and identify individuals with early stage cognitive impairment that can progress to Alzheimer’s disease. The 7 January 2011 issue of the journal Cell has an article by Opko and academic researchers describing the technology that screens Immunoglobulin G (IgG) antibodies with arrays of synthetic molecules to find disease biomarkers.

The Palm Beach Post reports yesterday that the initial research was done by researchers at University of Texas Southwest Medical Center in Dallas and Scripps Research Institute in Jupiter, Florida. Opko Health licensed the technology for further development and commercialization.

Read More: Engineers Develop Biomarker Breathalyzer Diagnostics

*     *     *

2 comments to Bristol-Myers Squibb, Biotech Partner on Alzheimer’s Test